Cowen analyst Yaron Werber raised the firm’s price target on Argenx to $458 from $441 and keeps an Outperform rating on the shares. The analyst updated the firm’s model to align with current Vyvgart sales trends, European launch expectations, and expansion into additional indications.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ARGX:
- argenx Announces Extraordinary General Meeting of Shareholders on February 27, 2023 to Appoint Steve Krognes as Non-Executive Director
- Argenx reports preliminary Q4 Vyvgart revenue $175M
- argenx Highlights 2023 Strategic Priorities Across Immunology Pipeline
- Argenx price target raised to EUR 500 from EUR 480 at JPMorgan
- Argenx included on Wells Fargo’s Tactical Ideas List for Q1 2023